Literature DB >> 26437067

Allogeneic hematopoietic cell transplantation for severe aplastic anemia: similar long-term overall survival after transplantation with related donors compared to unrelated donors.

B K Mortensen1, N Jacobsen1, C Heilmann2, H Sengeløv1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26437067     DOI： 10.1038/bmt.2015.231

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

1.  Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).

Authors:  Anna Locasciulli; Rosi Oneto; Andrea Bacigalupo; Gerard Socié; Elisabeth Korthof; Albert Bekassy; Hubert Schrezenmeier; Jakob Passweg; MoniKa Führer
Journal:  Haematologica       Date:  2007-01       Impact factor: 9.941

2.  Unrelated cord blood transplantation for newly diagnosed patients with severe acquired aplastic anemia using a reduced-intensity conditioning: high graft rejection, but good survival.

Authors:  H-L Liu; Z-M Sun; L-Q Geng; X-B Wang; K-Y Ding; B-I Tang; J Tong; Z-Y Wang
Journal:  Bone Marrow Transplant       Date:  2012-01-16       Impact factor: 5.483

3.  Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: a study by eurocord and the aplastic anemia working party of the European group for blood and marrow transplantation.

Authors:  Regis Peffault de Latour; Duncan Purtill; Annalisa Ruggeri; Guillermo Sanz; Gerard Michel; Virginie Gandemer; Sebastien Maury; Joanne Kurtzberg; Carmen Bonfim; Mahmoud Aljurf; Eliane Gluckman; Gerard Socié; Jakob Passweg; Vanderson Rocha
Journal:  Biol Blood Marrow Transplant       Date:  2010-06-16       Impact factor: 5.742

Review 4.  Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia.

Authors:  G Meyers; R T Maziarz
Journal:  Bone Marrow Transplant       Date:  2010-07-05       Impact factor: 5.483

5.  Recent improvement in outcome of unrelated donor transplantation for aplastic anemia.

Authors:  R Viollier; G Socié; A Tichelli; A Bacigalupo; E T Korthof; J Marsh; J Cornish; P Ljungman; R Oneto; A N Békássy; M Fuehrer; S Maury; H Schrezenmeier; M T van Lint; D Wojcik; A Locasciulli; J R Passweg
Journal:  Bone Marrow Transplant       Date:  2007-11-05       Impact factor: 5.483

6.  Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia.

Authors:  J R Passweg; W S Pérez; M Eapen; B M Camitta; E Gluckman; W Hinterberger; J M Hows; J C W Marsh; R Pasquini; H Schrezenmeier; G Socié; M-J Zhang; C Bredeson
Journal:  Bone Marrow Transplant       Date:  2006-04       Impact factor: 5.483

7.  Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia.

Authors:  Evelio D Perez-Albuerne; Mary Eapen; John Klein; Thomas J Gross; Jeffery M Lipton; K Scott Baker; Anne Woolfrey; Naynesh Kamani
Journal:  Br J Haematol       Date:  2008-02-26       Impact factor: 6.998

8.  Unrelated cord blood transplantation for severe aplastic anemia.

Authors:  Ayami Yoshimi; Seiji Kojima; Shuichi Taniguchi; Junichi Hara; Toshimitsu Matsui; Yoshiyuki Takahashi; Hiroshi Azuma; Koji Kato; Tokiko Nagamura-Inoue; Shunro Kai; Shunichi Kato
Journal:  Biol Blood Marrow Transplant       Date:  2008-09       Impact factor: 5.742

Review 9.  Haematopoietic stem cell transplantation for acquired aplastic anaemia.

Authors:  Moya E Young; Victoria Potter; Austin G Kulasekararaj; Ghulam J Mufti; Judith C Marsh
Journal:  Curr Opin Hematol       Date:  2013-11       Impact factor: 3.284
  9 in total
  5 in total

Review 1.  Hematopoietic stem cell transplantation for acquired aplastic anemia.

Authors:  George E Georges; Rainer Storb
Journal:  Curr Opin Hematol       Date:  2016-11       Impact factor: 3.284

Review 2.  Haploidentical stem cell transplantation for aplastic anemia: the current advances and future challenges.

Authors:  Zheng-Li Xu; Xiao-Jun Huang
Journal:  Bone Marrow Transplant       Date:  2020-12-15       Impact factor: 5.483

Review 3.  Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment.

Authors:  George E Georges; Kris Doney; Rainer Storb
Journal:  Blood Adv       Date:  2018-08-14

Review 4.  Allo-HSCT compared with immunosuppressive therapy for acquired aplastic anemia: a system review and meta-analysis.

Authors:  Yangmin Zhu; Qingyan Gao; Jing Hu; Xu Liu; Dongrui Guan; Fengkui Zhang
Journal:  BMC Immunol       Date:  2020-03-06       Impact factor: 3.615

Review 5.  Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow.

Authors:  Antonio G Solimando; Carmen Palumbo; Mary Victoria Pragnell; Max Bittrich; Antonella Argentiero; Markus Krebs
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.